ArticleCells2024

Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers.

Sara Manore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.